Miranda Sung

Miranda Sung is an accomplished pharmacologist with extensive experience in early drug discovery and development. Currently serving as Associate Director of Bioassays & Mechanistic Biology at insitro, Miranda leads a team of scientists to design target engagement screening assays and investigates target mechanisms of action. Previous roles include Senior Scientist II at Exelixis, where responsibilities included managing oncology studies and contributing to drug discovery strategies, and Senior Scientist at FibroGen, focusing on efficacy studies for oncology drug development. Miranda's academic background includes a PhD in Pharmacology from the University of Alberta, where significant research was conducted on energy metabolism, obesity, and diabetes. This robust expertise in pharmacology and cross-disciplinary collaboration has established Miranda as a key contributor in advancing drug discovery pipelines.